Drug Discovery Outsourcing Market Growth, Size, Trends, Share, Revenue and Future Outlook
Drug Discovery Outsourcing Market Size- By Workflow, By Therapeutic Area, By Drug Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033
| Published: Apr-2024 | Report ID: HLCA2436 | Pages: 1 - 234 | Formats*: |
| Category : Healthcare | |||
Drug Discovery Outsourcing Market Introduction and Overview
According to SPER Market Research, the Global Drug Discovery Outsourcing Market is estimated to reach USD 8.59 billion by 2033 with a CAGR of 7.71%.
The report includes an in-depth analysis of the Global Drug Discovery Outsourcing Market, including market size and trends, product mix, applications, and supplier analysis. The term "drug discovery outsourcing" refers to a strategy employed by several businesses to lower drug development expenses by contracting out some of the job to outside vendors. The first stage of the drug development process is known as drug discovery outsourcing, during which time operations in a variety of domains, including product production and drug discovery, can be outsourced. It is the process used to discover novel medications or pharmaceuticals in a variety of industries, including biotechnology, pharmacology, and pharmaceuticals. Outsourcing drug development leads to the discovery of novel medications or therapies in the biotechnology, pharmaceutical, and pharmacology fields.
- June 2020: AstraZeneca and Accent therapies partnered in June 2020 to create and market therapies that target RNA-modifying proteins in the fight against cancer.
- June 2022: Berkeley Lights, Inc. (Nasdaq: BLI), a pioneer in digital cell biology, and Curia, a top contract research, development, and manufacturing organization (CDMO), announced that Curia would be utilizing Berkeley Lights' Beacon® Optofluidic system and workflows to expedite and enhance its antibody-based drug discovery capabilities.
Market Opportunities and Challenges
One of the key reasons driving the growth and demand of the drug discovery outsourcing market is the increasing trend of collaborations in drug discovery research worldwide. The rising incidence of genetic, metabolic, and other chronic illnesses as well as technological developments in medication discovery are also driving the expansion of the worldwide market. Additionally, the market is growing due to the growing use of AI in drug development, as well as the quick transition toward biologics, patent expiration, and the historically large reduction in internal discovery at large pharmaceutical companies. Growing rates of medication and antibiotic resistance will also guarantee rapid industry expansion.
Existence of Drug Discovery Software Packages in Open-Source Format, Drug discovery is an expensive and time-consuming procedure. As a result of the tremendous momentum that in silico computational chemistry and molecular modeling have garnered in computer-aided drug creation, these techniques are being applied widely to find new molecules. Even if open-source software offers lower prices and more freedom, it seriously jeopardizes income creation. These platforms restrict the use of licensed software and versions, which hinders the expansion of the market. Open-source suppliers view licensing as the start of enduring partnerships wherein all parties collaborate to improve product efficacy and facilitate client success.
Market Competitive Landscape
The competitive landscape of the drug discovery outsourcing market includes information by competitor. The company's overview, financials, revenue, market potential, R&D investment, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance are all included in the details. Several notable entities in the worldwide Drug Discovery Outsourcing industry comprise Charles River Laboratories, Curia Global Inc., Dalton Pharma Service, Discover X Corporation, Dr. Reddy’s Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd., Thermo Fisher Scientific,Inc., TCG Life Science Pvt. Ltd.
Scope of the Report:
| Report Metric | Details |
| Market size available for years | 2020-2033 |
| Base year considered | 2023 |
| Forecast period | 2024-2033 |
| Segments covered | By Workflow, By Therapeutic Area, By Drug Type, By End User. |
| Regions covered | North America, Asia-Pacific, Latin America, Middle East & Africa and Europe |
| Companies Covered | Charles River Laboratories, Curia Global Inc, Dalton Pharma Service, Discover X Corporation, Dr. Reddy’s Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd, Thermo Fisher Scientific,Inc, TCG Life Science Pvt Ltd. |
COVID-19 Impact on Global Drug Discovery Outsourcing Market
The COVID-19 pandemic had a severe effect on the economy as a whole, causing a substantial downturn in 2020 in a number of industries. Due to the immense pressure placed on healthcare institutions to stop the spread of illness, the healthcare industry was among those most negatively affected by the epidemic. There was a small pause in certain non-COVID-19 related medication discovery and research operations during the early stages of the pandemic. It was observed that a number of corporations revised their clinical trial R&D spending in relation to prior investment. Nonetheless, quick recovery was noted because of the growing demand for the creation of a vaccine and potent medications to treat COVID-19.
Key Target Audience:
- Pharmaceutical Companies
- Biotechnology Companies
- Emerging Biopharmaceutical Start ups
- Contract Research Organizations
- Academia and Research Institutions
- Investors and Venture Capitalists
- Regulatory Agencies
- Healthcare Providers
- Non-Profit Organizations
- Government Agencies and Policy Makers
Our in-depth analysis of the Drug Discovery Outsourcing Market includes the following segments:
| By Workflow: |
|
| By Therapeutic Area: |
|
| By Drug Type: |
|
| By End User: |
|
Key Topics Covered in the Report:
- Global Drug Discovery Outsourcing Market Size (FY’2024-FY’2033)
- Overview of Global Drug Discovery Outsourcing Market
- Segmentation of Global Drug Discovery Outsourcing Market By Workflow (Target Validation and Functional Informatics, Lead Identification and Candidate Optimization, Preclinical Development, Target Identification and Screening, Others)
- Segmentation of Global Drug Discovery Outsourcing Market By Therapeutic Area (Cardiovascular, Central Nervous System, Gastrointestinal, Hematology, Respiratory System, Infectious Disease, Oncology, Immunology, Others).
- Segmentation of Global Drug Discovery Outsourcing Market By Drug Type (Small Molecules, Large Molecules)
- Segmentation of Global Drug Discovery Outsourcing Market By End User (Pharmaceutical and Biotechnology Companies, Academia Institutes, Others)
- Statistical Snap of Global Drug Discovery Outsourcing Market
- Expansion Analysis of Global Drug Discovery Outsourcing Market
- Problems and Obstacles in Global Drug Discovery Outsourcing Market
- Competitive Landscape in the Global Drug Discovery Outsourcing Market
- Impact of COVID-19 and Demonetization on Global Drug Discovery Outsourcing Market
- Details on Current Investment in Global Drug Discovery Outsourcing Market
- Competitive Analysis of Global Drug Discovery Outsourcing Market
- Prominent Players in the Global Drug Discovery Outsourcing Market
- SWOT Analysis of Global Drug Discovery Outsourcing Market
- Global Drug Discovery Outsourcing Market Future Outlook and Projections (FY’2024-FY’2033)
- Recommendations from Analyst
1. Introduction
1.1. Scope of the report1.2. Market segment analysis
2. Research Methodology
2.1. Research data source2.1.1. Secondary Data2.1.2. Primary Data2.1.3. SPER’s internal database2.1.4. Premium insight from KOL’s2.2. Market size estimation2.2.1. Top-down and Bottom-up approach2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis4.1.1. Drivers4.1.2. Restraints4.1.3. Opportunities4.1.4. Challenges4.2. COVID-19 Impacts of the Global Drug Discovery Outsourcing Market.
5. Market variable and outlook
5.1. SWOT Analysis5.1.1. Strengths5.1.2. Weaknesses5.1.3. Opportunities5.1.4. Threats5.2. PESTEL Analysis5.2.1. Political Landscape5.2.2. Economic Landscape5.2.3. Social Landscape5.2.4. Technological Landscape5.2.5. Environmental Landscape5.2.6. Legal Landscape5.3. PORTER’s Five Forces5.3.1. Bargaining power of suppliers5.3.2. Bargaining power of buyers5.3.3. Threat of Substitute5.3.4. Threat of new entrant5.3.5. Competitive rivalry5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Drug Discovery Outsourcing Market Manufacturing Base Distribution, Sales Area, Product Type6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Drug Discovery Outsourcing Market
7. Global Drug Discovery Outsourcing Market, By Workflow(USD Million) 2020-2033
7.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2020-20267.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Workflow, 2027-20337.3. Target Validation and Functional Informatics7.4. Lead Identification and Candidate Optimization7.5. Preclinical Development7.6. Target Identification and Screening7.7. Others
8. Global Drug Discovery Outsourcing Market, By Therapeutic Area(USD Million) 2020-2033
8.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2020-2026)8.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Therapeutic Area, (2027-2033)8.3. Cardiovascular8.4. Central Nervous System8.5. Gastrointestinal8.6. Haematology8.7. Respiratory System8.8. Infectious Disease8.9. Oncology8.10. Immunology8.11. Others
9. Global Drug Discovery Outsourcing Market, By Drug Type (USD Million) 2020-2033
9.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2020-2026)9.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By Drug Type, (2027-2033)9.3. Small Molecules9.4. Large Molecules
10. Global Drug Discovery Outsourcing Market, By End User (USD Million) 2020-2033
10.1. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2020-2026)10.2. Global Drug Discovery Outsourcing Market Size, Share and Forecast, By End User, (2027-2033)10.3. Pharmaceutical and Biotechnological Companies10.4. Academia Institutions10.5. Others
11. Global Drug Discovery Outsourcing Market Forecast, 2020-2033 (USD Million)
11.1. Global Drug Discovery Outsourcing Market Size and Market Share
12. Global Drug Discovery Outsourcing Market, By Region, 2020-2033 (USD Million)
12.2. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2027-2033)12.1. Global Drug Discovery Outsourcing Market Size and Market Share By Region (2020-2026)12.3. Asia-Pacific12.3.1. Australia12.3.2. China12.3.3. India12.3.4. Japan12.3.5. South Korea12.3.6. Rest of Asia-Pacific12.4. Europe12.4.1. France12.4.2. Germany12.4.3. Italy12.4.4. Spain12.4.5. United Kingdom12.4.6. Rest of Europe12.5. Middle East and Africa12.5.1. Kingdom of Saudi Arabia12.5.2. United Arab Emirates12.5.3. Qatar12.5.4. South Africa12.5.5. Egypt12.5.6. Morocco12.5.7. Nigeria12.5.8. Rest of Middle-East and Africa12.6. North America12.6.1. Canada12.6.2. Mexico12.6.3. United States12.7. Latin America12.7.1. Argentina12.7.2. Brazil12.7.3. Rest of Latin America
13. Company Profile
13.1. Charles River Laboratories13.1.1. Company details13.1.2. Financial outlook13.1.3. Product summary13.1.4. Recent developments13.2. Curia Global Inc.13.2.1. Company details13.2.2. Financial outlook13.2.3. Product summary13.2.4. Recent developments13.3. Dalton Pharma Service13.3.1. Company details13.3.2. Financial outlook13.3.3. Product summary13.3.4. Recent developments13.4. Dr. Reddy’s Laboratories13.4.1. Company details13.4.2. Financial outlook13.4.3. Product summary13.4.4. Recent developments13.5. Discover X Corporation13.5.1. Company details13.5.2. Financial outlook13.5.3. Product summary13.5.4. Recent developments13.6. Laboratory Corporation of America13.6.1. Company details13.6.2. Financial outlook13.6.3. Product summary13.6.4. Recent developments13.7. Merck & Co13.7.1. Company details13.7.2. Financial outlook13.7.3. Product summary13.7.4. Recent developments13.8. Syngene International Ltd.13.8.1. Company details13.8.2. Financial outlook13.8.3. Product summary13.8.4. Recent developments13.9. TCG Life Science Pvt. Ltd.13.9.1. Company details13.9.2. Financial outlook13.9.3. Product summary13.9.4. Recent developments13.10. Thermo Fisher Scientific, Inc.13.10.1. Company details13.10.2. Financial outlook13.10.3. Product summary13.10.4. Recent developments13.11. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
Drug Discovery Outsourcing Market is projected to reach USD 8.59 billion by 2033, growing at a CAGR of 7.71% during the forecast period.
Drug Discovery Outsourcing Market grew in market size from 2024. The Market is expected to reach USD 8.59 billion by 2033, at a CAGR of 7.71% during the forecast period.
Drug Discovery Outsourcing Market CAGR of 7.71% during the forecast period.
You can get the sample pages by clicking the link -Click Here
Drug Discovery Outsourcing Market size is USD 8.59 billion from 2024 to 2033.
Drug Discovery Outsourcing Market Segment is Covered By Workflow, By Therapeutic Area, By Drug Type, By End User.
The North America region is anticipated to have the highest market share in Drug Discovery Outsourcing Market.
The key players in the market include Companies Covered Charles River Laboratories, Curia Global Inc., Dalton Pharma Service, Discover X Corporation, Dr. Reddy’s Laboratories, Laboratory Corporation of America Holdings, Merck & Co, Syngene Intentional Ltd., Thermo Fisher Scientific,Inc., TCG Life Science Pvt. Ltd.
One of the key reasons driving the growth and demand of the drug discovery outsourcing market is the increasing trend of collaborations in drug discovery research worldwide.
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
